A genome-wide pleiotropy scan for prostate cancer risk

European Urology

Volumn 67, Issue 4, 2015, Pages 649-657

  Panagiotou, Orestis A ^a   Travis, Ruth C ^b   Campa, Daniele ^c   Berndt, Sonja I ^a   Lindstrom, Sara ^d   Kraft, Peter ^d   Schumacher, Fredrick R ^e   Siddiq, Afshan ^f   Papatheodorou, Stefania I ^g   Stanford, Janet L ^h   Albanes, Demetrius ^a   Virtamo, Jarmo ⁱ   Weinstein, Stephanie J ^a   Diver, W Ryan ^j   Gapstur, Susan M ^j   Stevens, Victoria L ^j   Boeing, Heiner ^k   Bueno De Mesquita, H Bas ^l,m,n,o   Barricarte Gurrea, Aurelio ^p,q   Kaaks, Rudolf ^c   Khaw, Kay Tee ^r   Krogh, Vittorio ^s   Overvad, Kim ^t   Riboli, Elio ^l   Trichopoulos, Dimitrios ^d,u,v   Giovannucci, Edward ^d,w   Stampfer, Meir ^d   Haiman, Christopher ^e   Henderson, Brian ^e   Le Marchand, Loic ^x   Gaziano, J Michael ^d,w,y   Hunter, David J ^d   Koutros, Stella ^a   Yeager, Meredith ^z   Hoover, Robert N ^a   Chanock, Stephen J ^a,z   Wacholder, Sholom ^a   Key, Timothy J ^b   Tsilidis, Konstantinos K ^b,aa   more..

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

^g CYPRUS UNIVERSITY OF TECHNOLOGY   (Cyprus)

^h Fred Hutchinson Cancer Research Center   (United States)

ⁱ NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^j AMERICAN CANCER SOCIETY   (United States)

^k GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^l IMPERIAL COLLEGE LONDON   (United Kingdom)

^m NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

ⁿ UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^o UNIVERSITY OF MALAYA   (Malaysia)

^p INSTITUTO DE SALUD PÚBLICA DE NAVARRA   (Spain)

^q CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^r UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^s NATIONAL CANCER INSTITUTE   (Italy)

^t AARHUS UNIVERSITY   (Denmark)

^u HELLENIC HEALTH FOUNDATION   (Greece)

^v BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^w HARVARD MEDICAL SCHOOL   (United States)

^x UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^y BRIGHAM AND WOMEN S HOSPITAL   (United States)

^z FREDERICK NATIONAL LABORATORY FOR CANCER RESEARCH   (United States)

^aa UNIVERSITY OF IOANNINA   (Greece)

more..

Author keywords

Aggressive prostate cancer; Genome wide association study; Glycine; Pleiotropy; Single nucleotide polymorphism

Indexed keywords

GLYCINE; PROSTATE SPECIFIC ANTIGEN;

AGGRESSION; ARTICLE; CANCER RISK; CANCER SCINTISCANNING; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC TRAIT; GENETIC VARIABILITY; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; META ANALYSIS (TOPIC); PHENOTYPE; PLEIOTROPY; PRIORITY JOURNAL; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM; DISEASE COURSE; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; META ANALYSIS; METABOLISM; PROCEDURES; PROGNOSIS; PROSTATE TUMOR; RISK FACTOR;

DISEASE PROGRESSION; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; GLYCINE; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; PROSTATIC NEOPLASMS; RISK FACTORS;

EID: 84923075918     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2014.09.020     Document Type: Article

References (45)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA Cancer J Clin 63 2013 11 30
2. R. Eeles, C. Goh, and E. Castro The genetic epidemiology of prostate cancer and its clinical implications Nat Rev Urol 11 2014 18 31
3. A.A. Al Olama, Z. Kote-Jarai, and F.R. Schumacher A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease Hum Mol Genet 22 2013 408 415
4. J.P. Ioannidis, R. Tarone, and J.K. McLaughlin The false-positive to false-negative ratio in epidemiologic studies Epidemiology 22 2011 450 456
5. S. Wacholder On standards of evidence Epidemiology 22 2011 464 466
6. P. Vineis, P. Brennan, and F. Canzian Expectations and challenges stemming from genome-wide association studies Mutagenesis 23 2008 439 444
7. O.A. Panagiotou, E. Evangelou, and J.P. Ioannidis Genome-wide significant associations for variants with minor allele frequency of 5% or less - an overview: a HuGE review Am J Epidemiol 172 2010 869 889
8. L.C. Lazzeroni, Y. Lu, and I. Belitskaya-Levy P-values in genomics: apparent precision masks high uncertainty Mol Psychiatry 19 2014 1336 1340
9. L.A. Hindorff, P. Sethupathy, and H.A. Junkins Potential etiologic and functional implications of genome-wide association loci for human diseases and traits Proc Natl Acad Sci U S A 106 2009 9362 9367
10. O.A. Panagiotou, C.J. Willer, J.N. Hirschhorn, and J.P. Ioannidis The power of meta-analysis in genome-wide association studies Annu Rev Genomics Hum Genet 14 2013 441 465
11. B.L. Pierce, and H. Ahsan Genome-wide "pleiotropy scan" identifies HNF1A region as a novel pancreatic cancer susceptibility locus Cancer Res 71 2011 4352 4358
12. V.W. Setiawan, F. Schumacher, and J. Prescott Cross-cancer pleiotropic analysis of endometrial cancer: PAGE and E2C2 consortia Carcinogenesis 35 2014 2068 2073
13. I. Cheng, J.M. Kocarnik, and L. Dumitrescu Pleiotropic effects of genetic risk variants for other cancers on colorectal cancer risk: PAGE, GECCO and CCFR consortia Gut 63 2014 800 807
14. N. Solovieff, C. Cotsapas, P.H. Lee, S.M. Purcell, and J.W. Smoller Pleiotropy in complex traits: challenges and strategies Nat Rev Genet 14 2013 483 495
15. J.D. Figueroa, Y. Ye, and A. Siddiq Genome-wide association study identifies multiple loci associated with bladder cancer risk Hum Mol Genet 23 2014 1387 1398
16. Z. Kote-Jarai, A.A. Al Olama, and G.G. Giles Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study Nat Genet 43 2011 785 791
17. S. Mocellin, D. Verdi, and K.A. Pooley Telomerase reverse transcriptase locus polymorphisms and cancer risk: a field synopsis and meta-analysis J Natl Cancer Inst 104 2012 840 854
18. T.E. Fingerlin, E. Murphy, and W. Zhang Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis Nat Genet 45 2013 613 620
19. F.R. Schumacher, S.I. Berndt, and A. Siddiq Genome-wide association study identifies new prostate cancer susceptibility loci Hum Mol Genet 20 2011 3867 3875
20. R.A. Eeles, A.A. Al Olama, and S. Benlloch Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array Nat Genet 45 2013 385 391
21. O.A. Panagiotou, and J.P. Ioannidis for the Genome-Wide Significance Project. What should the genome-wide significance threshold be?. Empirical replication of borderline genetic associations Int J Epidemiol 41 2012 273 286
22. A.D. Johnson, R.E. Handsaker, S.L. Pulit, M.M. Nizzari, C.J. O'Donnell, and P.I. de Bakker SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap Bioinformatics 24 2008 2938 2939
23. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557 560
24. A. Tenesa, S.M. Farrington, and J.G. Prendergast Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21 Nat Genet 40 2008 631 637
25. R.A. Eeles, Z. Kote-Jarai, and G.G. Giles Multiple newly identified loci associated with prostate cancer susceptibility Nat Genet 40 2008 316 321
26. G. Thomas, K.B. Jacobs, and M. Yeager Multiple loci identified in a genome-wide association study of prostate cancer Nat Genet 40 2008 310 315
27. D.B. Hancock, M.S. Artigas, and S.A. Gharib Genome-wide joint meta-analysis of SNP and SNP-by-smoking interaction identifies novel loci for pulmonary function PLoS Genet 8 2012 e1003098
28. R.A. Eeles, Z. Kote-Jarai, and A.A. Al Olama Identification of seven new prostate cancer susceptibility loci through a genome-wide association study Nat Genet 41 2009 1116 1121
29. J. Gudmundsson, P. Sulem, and V. Steinthorsdottir Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes Nat Genet 39 2007 977 983
30. K. Suhre, S.Y. Shin, and A.K. Petersen Human metabolic individuality in biomedical and pharmaceutical research Nature 477 2011 54 60
31. S. Koutros, T.E. Meyer, and S.D. Fox Prospective evaluation of serum sarcosine and risk of prostate cancer in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Carcinogenesis 34 2013 2281 2285
32. T.A. Manolio, L.D. Brooks, and F.S. Collins A HapMap harvest of insights into the genetics of common disease J Clin Invest 118 2008 1590 1605
33. T.A. Manolio, F.S. Collins, and N.J. Cox Finding the missing heritability of complex diseases Nature 461 2009 747 753
34. J.H. Park, S. Wacholder, and M.H. Gail Estimation of effect size distribution from genome-wide association studies and implications for future discoveries Nat Genet 42 2010 570 575
35. I. Tomlinson, E. Webb, and L. Carvajal-Carmona A genome-wide association scan of tag SNPs identifies a susceptibility variant for colorectal cancer at 8q24.21 Nat Genet 39 2007 984 988
36. S. Guarrera, F. Ricceri, and S. Polidoro Association between total number of deaths, diabetes mellitus, incident cancers, and haplotypes in chromosomal region 8q24 in a prospective study Am J Epidemiol 175 2012 479 487
37. C.C. Chung, and S.J. Chanock Current status of genome-wide association studies in cancer Hum Genet 130 2011 59 78
38. S. Wacholder, M. Yeager, and L.M. Liao Invited commentary: more surprises from a gene desert Am J Epidemiol 175 2012 488 491
39. C. Grisanzio, and M.L. Freedman Chromosome 8q24-associated cancers and MYC Genes Cancer. 1 2010 555 559
40. A. Sreekumar, L.M. Poisson, and T.M. Rajendiran Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression Nature 457 2009 910 914
41. M. Pavlou, and E.P. Diamandis The search for new prostate cancer biomarkers continues Clin Chem 55 2009 1277 1279
42. S. de Vogel, A. Ulvik, and K. Meyer Sarcosine and other metabolites along the choline oxidation pathway in relation to prostate cancer - a large nested case-control study within the JANUS cohort in Norway Int J Cancer 134 2014 197 206
43. A. Ziegler, I.R. Konig, and J.R. Thompson Biostatistical aspects of genome-wide association studies Biometr J 50 2008 8 28
44. N. Pashayan, S.W. Duffy, and S. Chowdhury Polygenic susceptibility to prostate and breast cancer: implications for personalised screening Br J Cancer 104 2011 1656 1663
45. M.J. Khoury, A.C. Janssens, and D.F. Ransohoff How can polygenic inheritance be used in population screening for common diseases? Genet Med 15 2013 437 443